InvestorsHub Logo
Followers 42
Posts 8448
Boards Moderated 2
Alias Born 11/14/2019

Re: Stuville post# 13249

Tuesday, 11/08/2022 10:10:30 AM

Tuesday, November 08, 2022 10:10:30 AM

Post# of 20427
Scary thing about Paxlovid's 3CL Protease Inhibitor ,nirmatrelvir, is that not only was the 5 days protocol apparently not enough but ,

".... the recent studies suggest the virus is poised to develop resistance—a fate that befalls many antiviral drugs. Two preprints posted on bioRxiv on 7 June, for example, show that SARS-coV-2 grown in the lab quickly gains the ability to avoid nirmatrelvir’s attack. Two research groups independently cultured the coronavirus with low levels of nirmatrelvir, killing some but not all of the virus. " Quote

https://www.science.org/content/article/bad-news-paxlovid-coronavirus-can-find-multiple-ways-evade-covid-19-drug
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TOMDF News